Active ingredientEtoposideCat. No. P-E139-001CAS 33419-42-0Family · Pharmaceutical analytical standards
Etoposide
An anticancer drug that blocks topoisomerase II, a semi-synthetic derivative of podophyllotoxin: first synthesised in 1966 and approved in the United States in 1983, it is used for testicular and lung cancers. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?The parent compound podophyllotoxin is extracted from the rhizome of the mayapple, Podophyllum peltatum, a North American woodland plant also called American mandrake.
Go to the active ingredient →Active ingredientEtoposideCat. No. P-E139-001CAS 33419-42-0
Active ingredientEtoposide PhosphateCat. No. P-E139-002CAS 117091-64-2
Pharmacopoeial impurityEtoposide EP Impurity ACat. No. P-E139-003CAS 124151-67-3
Pharmacopoeial impurityEtoposide EP Impurity BCat. No. P-E139-004CAS 100007-56-5
Pharmacopoeial impurityEtoposide EP Impurity CCat. No. P-E139-005CAS 100007-53-2
Pharmacopoeial impurityEtoposide EP Impurity DCat. No. P-E139-006CAS 23363-35-1
Pharmacopoeial impurityEtoposide EP Impurity ECat. No. P-E139-007CAS 6559-91-7
Pharmacopoeial impurityEtoposide EP Impurity FCat. No. P-E139-008
Pharmacopoeial impurityEtoposide EP Impurity GCat. No. P-E139-009
Pharmacopoeial impurityEtoposide EP Impurity HCat. No. P-E139-010CAS 102306-95-6
Pharmacopoeial impurityEtoposide EP Impurity ICat. No. P-E139-011CAS 111712-42-6
Pharmacopoeial impurityEtoposide EP Impurity JCat. No. P-E139-012CAS 118356-05-1
Pharmacopoeial impurityEtoposide EP Impurity KCat. No. P-E139-013
Pharmacopoeial impurityEtoposide EP Impurity LCat. No. P-E139-014CAS 40505-27-9
Pharmacopoeial impurityEtoposide EP Impurity NCat. No. P-E139-015
Pharmacopoeial impurityEtoposide EP Impurity OCat. No. P-E139-016
Pharmacopoeial impurityEtoposide EP Impurity PCat. No. P-E139-017CAS 117669-31-5
Pharmacopoeial impurityEtoposide EP Impurity QCat. No. P-E139-018CAS 153975-26-9
Pharmacopoeial impurityEtoposide EP Impurity RCat. No. P-E139-019CAS 149839-65-6
Isotopically labelledEtoposide-13C-d3Cat. No. P-E139-020
Isotopically labelledEtoposide-d3Cat. No. P-E139-021
Impurity4,6-O-(1R)-Ethylidene-D-glucoseCat. No. P-E139-023CAS 105453-33-6
ImpurityEtoposide Acyl Chloride ImpurityCat. No. P-E139-024
ImpurityEtoposide Hydroxy AcidCat. No. P-E139-025
ImpurityEtoposide Impurity 1Cat. No. P-E139-026CAS 153975-25-8
ImpurityEtoposide Impurity 2Cat. No. P-E139-027
ImpurityEtoposide Impurity 4Cat. No. P-E139-029CAS 2682936-91-8
ImpurityEtoposide Impurity 5Cat. No. P-E139-030
ImpurityEtoposide Impurity 6Cat. No. P-E139-031CAS 101648-60-6
ImpurityEtoposide Impurity 7Cat. No. P-E139-033CAS 171971-86-1
ImpurityEtoposide Impurity 8Cat. No. P-E139-034CAS 89709-04-6
ImpurityEtoposide Impurity 9Cat. No. P-E139-035CAS 105016-65-7
ImpurityEtoposide monoacetylchloride (Mixture of Diastereomers)Cat. No. P-E139-036
ImpurityEtoposide monoacetylchloride (SRRR Isomer)Cat. No. P-E139-037
ImpurityEtoposide Triacyl Chloride ImpurityCat. No. P-E139-038
ImpurityEtoposide Triacyl Chloride Impurity (mixture of diastereomers)Cat. No. P-E139-039
Impuritycis-Etoposide Hydroxy Acid Sodium SaltCat. No. P-E139-040No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceEtoposide CRSEDQM code E2600000Family EtoposideNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.